Cancer treatment has seen significant advancements in recent years with the introduction of innovative therapies. AstraZeneca’s Imfinzi (durvalumab) has emerged as a key contributor in this evolution.

Both Tagrisso and Imfinzi have been recommended by England’s NICE to treat patients with lung cancer in England and Wales. Credit: Roland Magnusson via Getty Images. · Pharmaceutical Technology ...

AstraZeneca (AZ) has received two separate recommendations from the National Institute for Health and Care Excellence (NICE) for use of its lung cancer drugs Tagrisso (osimertinib) and Imfinzi ...

Both Tagrisso and Imfinzi have been recommended by England’s NICE to treat patients with lung cancer in England and Wales. Credit: Roland Magnusson via Getty Images. AstraZeneca has received two ...

Speaking in Jammu’s Akhnoor at a function to mark Armed Forces Veterans Day on January 14, Rajnath said Indian forces had succeeded in unfurling the Tricolour at Haji Pir in 1965, and “if it was not ...

Security forces successfully thwarted infiltration attempt by the terrorists along the Pakistan-Afghanistan Border and five Khwarij were gunned down in Sambaza area of Zhob district last night.

The FDA has kicked off a priority review of AstraZeneca's checkpoint inhibitor Imfinzi for biliary tract cancer (BTC), setting up what could be approval for an immunotherapy for the group of rare ...

There is a commercial access agreement for durvalumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or returning to patients, according to a new study. Patients were given ...

Two late-stage studies published Wednesday in The Lancet show that Astra’s Imfinzi and Merck’s Keytruda delayed the progress of liver cancer when combined with other drugs and a local treatment.